Provided by Tiger Trade Technology Pte. Ltd.

Bolt Biotherapeutics, Inc.

4.56
-0.2100-4.40%
Post-market: 4.560.00000.00%17:41 EDT
Volume:52.51K
Turnover:244.17K
Market Cap:8.75M
PE:-0.28
High:4.92
Open:4.72
Low:4.48
Close:4.77
52wk High:7.20
52wk Low:3.91
Shares:1.92M
Float Shares:1.44M
Volume Ratio:1.93
T/O Rate:3.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-16.3353
EPS(LYR):-17.8500
ROE:-88.79%
ROA:-28.12%
PB:0.44
PE(LYR):-0.26

Loading ...

Bolt Biotherapeutics Holds 2026 Annual Stockholder Meeting

TIPRANKS
·
Jun 12

Bolt Biotherapeutics shareholders elect Quinn, Dupont to board class II seats

Reuters
·
Jun 12

BRIEF-Bolt, Pony.Ai, Stellantis To Launch Autonomous Mobility Testing Program In Luxembourg

Reuters
·
Jun 09

Bolt, Stellantis, Pony.ai to launch autonomous vehicle test program in Luxembourg

Reuters
·
Jun 09

Bolt Biotherapeutics Initiated at Buy by Rodman & Renshaw

Dow Jones
·
May 29

Bolt Biotherapeutics initiated with a Buy at Rodman & Renshaw

TIPRANKS
·
May 29

Bolt Biotherapeutics Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
May 28

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 28

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bolt Biotherapeutics (BOLT) and Upstream Bio, Inc. (UPB)

TIPRANKS
·
May 14

Bolt Biotherapeutics Q1 EPS $(4.31) Misses $(2.85) Estimate, Sales $26.000K Miss $1.500M Estimate

Benzinga
·
May 13

Bolt Biotherapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Bolt Biotherapeutics Q1 FY26 net loss narrows to $7.24 million; revenue drops to $26,000

Reuters
·
May 13

Bolt Biotherapeutics, Inc. Q1 Operating Expenses USD 7.627 Million

THOMSON REUTERS
·
May 13

Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 13

Bolt Biotherapeutics Inc expected to post a loss of $2.85 a share - Earnings Preview

Reuters
·
May 08

Bolt Biotherapeutics announces annual shareholder meeting

Reuters
·
Apr 29

Bolt Metals Names Veteran Finance Executive as New CFO and Corporate Secretary

TIPRANKS
·
Apr 10

JonesTrading Keeps Their Hold Rating on Bolt Biotherapeutics (BOLT)

TIPRANKS
·
Apr 07

Bolt Biotherapeutics Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 13

Bolt Metals Raises $6 Million in Fully Subscribed Private Placement

TIPRANKS
·
Feb 26